原发性肝癌(简称肝癌)是常见而预后极差的疾病。由于症状隐匿,难以早期发现,当症状、体征出现而就医时,多数已届中晚期,常失去手术切除的机会。自血清甲胎蛋白(AFP)检测用于肝癌普查以来,国内在早期肝癌的诊治方面积累了不少经验,肝癌的5年生存率已可达72.9％。我院手术切除的肝癌5年生存率为20.0％。为了进一步提高 Primary liver cancer (abbreviated as liver cancer) is a common disease with a very poor prognosis. Because the symptoms are hidden, it is difficult to find it early. When the symptoms and signs appear, the majority of patients have been in the middle and late stages and often have lost the chance of surgical resection. Since the detection of serum alpha-fetoprotein (AFP) for liver cancer screening, the country has accumulated a lot of experience in the diagnosis and treatment of early liver cancer, and the 5-year survival rate of liver cancer has reached 72.9%. The 5-year survival rate of surgical resection of liver cancer in our hospital was 20.0%. To further improve